Kazia Therapeutics (KZIA) Deferred Taxes (2016 - 2022)

Kazia Therapeutics' Deferred Taxes history runs 5 years deep, the most recent figure standing at -$89056.7 for Q4 2022.

• Quarterly Deferred Taxes rose 61.31% year-over-year to -$89056.7 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was -$530087.0 (down 8.22% YoY) and the FY2017 annual result came in at -$149304.5, changed N/A from the prior year.
• Deferred Taxes was -$89056.7 for Q4 2022 at Kazia Therapeutics, up from -$230187.3 in the prior quarter.
• Across five years, Deferred Taxes topped out at -$89056.7 in Q4 2022 and bottomed at -$230187.3 in Q4 2021.
• A 4-year average of -$132521.7 and a median of -$105421.5 in 2020 frame the typical range for Deferred Taxes.
• Annual changes were most pronounced in 2021 — Deferred Taxes slumped 111.22% — and 2022, when it soared 61.31%.
• Kazia Therapeutics' Deferred Taxes stood at -$101862.1 in 2019, then retreated by 6.99% to -$108980.9 in 2020, then slumped by 111.22% to -$230187.3 in 2021, then surged by 61.31% to -$89056.7 in 2022.
• Business Quant data shows KZIA's Deferred Taxes at -$89056.7 in Q4 2022, -$230187.3 in Q4 2021, and -$108980.9 in Q4 2020.